BTAIVSPCSA• 6 Months (Normalized)
BTAI vs PCSA (BioXcel Therapeutics Inc. vs Processa Pharmaceuticals Inc.)
Showing Closing Date Range from Mar, 15 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BTAI Performance $0.05
-96.69%
BioXcel Therapeutics Inc.
Normalized Baseline0.00%
PCSA Performance $2.08
-33.33%
Processa Pharmaceuticals Inc.
Normalized Baseline0.00%
Alpha Spread Margin PCSA LEADS
-63.36%
PCSA outperforming by 63.36%
BTAIPCSA
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BTAI PCSA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(125 dates)
| Date | BTAI Price | BTAI Gain (%) | PCSA Price | PCSA Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $0.05 | -96.69% | $2.08 | -33.33% | -63.36% |
| Sep 10, 2026 | $0.05 | -96.75% | $1.85 | -40.71% | -56.04% |
| Sep 09, 2026 | $0.05 | -96.95% | $1.99 | -36.22% | -60.73% |
| Sep 08, 2026 | $0.04 | -97.21% | $2.16 | -30.77% | -66.44% |
| Sep 04, 2026 | $0.07 | -95.19% | $2.06 | -33.97% | -61.22% |
| Sep 03, 2026 | $0.12 | -92.34% | $2.05 | -34.29% | -58.05% |
| Sep 02, 2026 | $0.11 | -93.05% | $2.10 | -32.69% | -60.36% |
| Sep 01, 2026 | $0.14 | -91.10% | $2.05 | -34.29% | -56.81% |
| Aug 31, 2026 | $0.16 | -89.42% | $2.05 | -34.29% | -55.13% |
| Aug 28, 2026 | $0.18 | -88.25% | $2.06 | -33.97% | -54.28% |
| Aug 27, 2026 | $0.72 | -53.31% | $2.11 | -32.37% | -20.94% |
| Aug 26, 2026 | $0.78 | -49.35% | $2.13 | -31.73% | -17.62% |
| Aug 25, 2026 | $0.74 | -51.82% | $2.18 | -30.13% | -21.69% |
| Aug 24, 2026 | $0.76 | -50.58% | $2.17 | -30.45% | -20.13% |
| Aug 21, 2026 | $0.80 | -47.79% | $2.08 | -33.33% | -14.46% |
Page 1 of 9